Kusajili – Clinical trials directory

Result of your search per sponsor: Ulrich Mrowietz, MD, Prof

Woman and Man Max 99 years
Ulrich Mrowietz, MD, Prof Update Il y a 4 ans

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis The aim of the study is to evaluate the efficacy and safety of LAS41008 in comparison to active control and placebo in patients with moderate to severe chronic plaque psoriasis

Country Austria, Germany, Netherlands, Poland
organs None
Specialty None

Closed trial

More information